ICUSeaStar Medical Holding Corp
Is SeaStar Medical Holding struggling financially?
Yes, by its own account. SeaStar Medical Holding told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.
Going concern disclosed May 2026
30/100
Fragile
- Sector
- Biotech/Pharma
- Market cap
- $14.8M
- Source filing
- 10-Q 13 May 2026
- Balance sheet
- 30 Jun 2026
Cash runway
Not estimable
The latest filings do not carry the cash or cash-flow lines needed to estimate a runway. Publishing a number here would mean inventing one.
What it reported
Cash burned over the last 12 months
$22.1M
What SeaStar Medical Holding told the SEC
…for at least 12 months from the issuance of these unaudited condensed consolidated financial statements. The Company believes that these conditions raise substantial doubt about its ability to continue as a going concern. The Company’s need for additional capital will depend in part on the scope and costs of its development activities. To date, the Company has generated approximately $ 1.9 million…
SeaStar Medical Holding Corp, Form 10-Q, filed 13 May 2026.
Read the filing on SEC.govWhat this means
- Not a bankruptcy filing, and not a prediction.
- It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
- The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.
Other Biotech/Pharma companies that filed the doubt
- CPHI China Pharma Holdings $42.2M
- ELOX Eloxx Pharmaceuticals $84.7M
- ENVB Enveric Biosciences $6.4M
- IVF INVO Fertility $2.7M
- JUNS Jupiter Neurosciences $4.8M
- LABT Lakewood-Amedex Biotherapeutics $5.3M